DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 10Dr. Reddy's Laboratories
02 2Breckenridge Pharmaceutical
03 2NanoAlvand
04 12Accord healthcare
05 2Accure Labs
06 2Actavis Inc
07 2Adcock Ingram
08 4Alphapharm PTY Ltd
09 3Apotex Inc
10 6Astellas Pharma
11 2Auro Pharma Inc
12 2Aurobindo Pharma Limited
13 1Aurogen South Africa (Pty) Ltd
14 1Azurity Pharma
15 1Baxter Healthcare Corporation
16 2Biem Ilac San. ve Tic. A.S
17 5CEPHALON INC
18 3CPS Cito Pharma Services GmbH
19 2Capstone Development Services
20 2CinnaGen
21 2Clinigen Group
22 1Dr Reddy's Laboratories (Pty) Ltd
23 2EG SpA
24 1EUGIA PHARMA INC.
25 2Eagle Pharmaceuticals
26 2Eriochem S.A.
27 2Fresenius Kabi Oncology Limited
28 1Fresenius Kabi USA
29 1GetWell Pharmaceutical
30 2Glenmark Pharmaceuticals
31 2Hetero Drugs
32 5Hospira, Inc.
33 2Innopharma Inc
34 1Jodas Expoim Pvt. Ltd
35 4Juno Pharmaceuticals Pty Ltd
36 4Kiara Health
37 2MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH
38 2Meitheal Pharmaceuticals
39 2Nang Kuang Pharmaceutical Co. Ltd.
40 2Naprod Life Sciences
41 1Natco Pharma
42 2Natco Pharma (Canada) Inc
43 2PHARMOBEDIENT
44 1Panacea Biotec Limited
45 1Pfizer Inc
46 1SEACROSS PHARMACEUTICALS
47 1Sakar Healthcare
48 8Sandoz B2B
49 2Teva Pharmaceutical Industries
50 2TherDose Pharma
51 2Vama Lifecare
52 2Viatris
53 1Vinkem Labs Ltd
54 1XYZ Pharma
01 4Bendamustina 100Mg 5 Units Parenteral Use
02 1Bendamustina 25Mg 20 Joined The Parenteral Use
03 4Bendamustina 25Mg 5 Units Parenteral Use
04 8Dry Sub
05 1FREEZE-DRIED POWDER
06 1INF
07 1INJECTABLE; INJECTION
08 4INJECTION
09 1Infusion
10 2Injectable
11 14Injection
12 1Liquid Injection
13 1Lyo.Inj
14 1Lyophilised Injection
15 1Lyophilized Injection
16 2Lyophilized Powder for Solution for Infusion
17 11POI
18 2POWDER FOR CONCENTRATE FOR
19 11POWDER FOR SOLUTION
20 18POWDER;INTRAVENOUS
21 8POWDER;IV (INFUSION)
22 1PULVER TILL KONCENTRAT TILL
23 8Powder to concentrate to the infusion fluid, resolution
24 1SOLUTION
25 12SOLUTION;INTRAVENOUS
26 1SOLUTION;IV (INFUSION)
27 1Trockensub
28 2Vial
29 12Blank
01 14DISCN
02 19Generic
03 1Lead Market Dossiers- Approved in EU
04 4Lead Market Dossiers- Filed
05 2Lead Market Dossiers- Tentative\nApproved in US
06 15RX
07 80Blank
01 1BELRAPZO
02 32BENDAMUSTINE HYDROCHLORIDE
03 7BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
04 1BENDAWEL
05 1BENDEKA
06 1BENVYON
07 1Baximo 100 mg
08 1Baximo 25 mg
09 2Beastin
10 1Bendahet 100
11 1Bendahet 25
12 1Bendamustin Accord
13 2Bendamustin Actavis
14 6Bendamustina
15 1Bendamustine 180mg/4ml DRL
16 5Bendamustine Accord
17 2Bendamustine Fresenius Kabi
18 4Bendamustine Juno
19 8Bendamustine Sandoz
20 4Bendamustine Viatris
21 4Bendanit
22 2ERIOTIB
23 1Equiben 100
24 1Equiben 25
25 5Levact
26 2NAT-BENDAMUSTINE
27 1Omuben 100mg
28 3Ribomustin
29 2Ribomustin 100 mg
30 2Ribomustin 25 mg
31 1Ribovact
32 2THERMUSTINE
33 7TREANDA
34 1VIVIMUSTA
35 19Blank
01 2Argentina
02 12Australia
03 12Canada
04 21India
05 4Iran
06 9Italy
07 8Norway
08 12South Africa
09 3Sweden
10 9Switzerland
11 2Turkey
12 40USA
13 1United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2022-12-07
Application Number : 205376
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2023-02-14
Application Number : 205447
Regulatory Info : DISCN
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Bendanit
Dosage Form : Vial
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2022-12-07
Application Number : 205376
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 100MG/4ML (25MG/ML)
Packaging :
Approval Date : 2025-07-03
Application Number : 219014
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 45MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in EU
Registration Country : India
Brand Name :
Dosage Form : Infusion
Dosage Strength : 180MG/4ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2023-02-14
Application Number : 205447
Regulatory Info : DISCN
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Bendanit
Dosage Form : Vial
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : RX
Registration Country : USA
Brand Name : TREANDA
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2008-03-20
Application Number : 22249
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREANDA
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2009-05-01
Application Number : 22249
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TREANDA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 45MG/0.5ML (90MG/ML)
Packaging :
Approval Date : 2013-09-13
Application Number : 22249
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TREANDA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 180MG/2ML (90MG/ML)
Packaging :
Approval Date : 2013-09-13
Application Number : 22249
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : TREANDA
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 22303
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;IV (INFUSION)
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number : 204086
Regulatory Info :
Registration Country : USA
